IGF2 mRNA-binding protein 2 (IGF2BP2), also known as IMP2, was found to be an HMGA2 target gene during early embryonic development. IGF2BP2 belongs to a family of RNA-binding proteins that contain six characteristics of RNA-binding modules, including two N-terminal RNA recognition motifs (RRM1 and RRM2) and four C-terminal hnRNP K-homology (KH1&KH4) domains. Its homolog, IGF2BP1/IMP1, has been shown to be essential for normal embryonic growth and development.
Product Name- Recombinant Human IGF2BP2
Aliases- Insulin-like growth factor 2 mRNA-binding protein 2, IGF2 mRNA-binding protein 2, µmP-2, Hepatocellular carcinoma autoantigen p62, IGF-II mRNA-binding protein 2, VICKZ family member 2, VICKZ2
- Recombinant Human IGF2BP2 (IGF2BP2)
Formulation- Recombinant Human IGF2BP2 is lyophilized from 0.2 µm filtered PBS solution, pH7.2 , 5% Trehalose.
Endotoxin Level- <1.0 EU/µg of recombinant protein as determined by the LAL method.
Storage Condition- Recombinant IGF2BP2 can be stored in working aliquots at +2° to +8°C for one month, or at -20°C to -70°C for twelve months.
Avoid repeated freeze/thaw cycles.